We’re attending #AHA24 where we’ll be celebrating 100 years of the American Heart Association! We look forward to hearing the latest in cardiovascular research and sharing details on our Phase 3 Librexia program, in collaboration with @bmsnews. Learn more: t.co/eVvbI3rqM3 t.co/JNsFPdmihC